Back

Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms Experimental Heart Failure HFA Premium Access Heart Failure 2018

About the speaker

Photo
Mrs Maria Del Carmen Asensio

University of Murcia, Murcia (Spain)

46 More presentations in this session

Presentation thumbnail
Professor H. Sabbah (Detroit, US)
Abstract Slides
Presentation thumbnail
Mr M. Lichy (Bratislava, SK)
Abstract
Presentation thumbnail
Doctor M. Gawor (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor M. Vanderheyden (Aalst, BE)
Abstract
Presentation thumbnail
Mr J. Berg (Lund, SE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Basic Science - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Endothelial NADPH oxidases protect against sympathetic nervous system hyperactivity-induced cardiac dysfunction and remodeling in mice: contribution of SGLT2
27 August 2021
thumbnail
Congress Presentation
Glabridin improves cardiac remodeling after myocardial infarction by activating PPAR to regulate the ubiquitination and degradation of EGFR
14 April 2026
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Presentation
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources